Harrow Health Inc
Change company Symbol lookup
Select an option...
HROW Harrow Health Inc
IWSY ImageWare Systems Inc
AMPX Amprius Technologies Inc
TNC Tennant Co
CVX Chevron Corp
ACGLO Arch Capital Group Ltd
AAPL Apple Inc
BCSF Bain Capital Specialty Finance Inc
HPE Hewlett Packard Enterprise Co
CCRN Cross Country Healthcare Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Harrow Health, Inc. is an eyecare pharmaceutical company. The Company is focused on the discovery, development, and commercialization of ophthalmic therapies. The Company serves ophthalmologists and optometrists by providing branded ophthalmic pharmaceuticals and compounded prescription medicines. The Company's specializes in the development, production, sale and distribution of prescription medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns the United States commercial rights to approximately 10 branded ophthalmic pharmaceutical products, including IHEEZO, IOPIDINE (both approved concentrations), MAXITROL eye drops, MOXEZA, ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name.

Price
Delayed
$20.51
Day's Change
0.4941 (2.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
21.14
Day's Low
20.03
Volume
(Light)

Today's volume of 64,808 shares is on pace to be much lighter than HROW's 10-day average volume of 554,396 shares.

64,808
  • Prev Close
    20.02
  • Today's Open
    20.03
  • Day's Range
    20.03-21.14
  • Avg Vol (10-day)
    554.4K
  • Last (time)
    10:57a ET 06/06/23
  • Last (size)
    100
  • 52-Wk Range
    6.00 - 28.25
    LowHigh
  • (06/16/22 - 05/10/23)
    27.38%
  • 68.3%
  • Market Cap
    617.9M
  • Shares Outstanding
    30.1M
  • -0.65
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 65.99
  • (% of float 05/15/23)
    7.89

Latest News

May 17, 2023
8:00 am ET
BusinessWire
May 16, 2023
11:45 am ET
PR Newswire
May 11, 2023
4:01 pm ET
BusinessWire
May 10, 2023
7:06 pm ET
Newsfile
May 05, 2023
8:15 pm ET
Newsfile
May 04, 2023
8:00 am ET
BusinessWire
May 02, 2023
7:00 am ET
BusinessWire
May 01, 2023
7:33 pm ET
Newsfile
April 27, 2023
8:00 am ET
BusinessWire
7:05 am ET
Zacks
April 24, 2023
7:33 pm ET
Newsfile
April 21, 2023
8:15 pm ET
Newsfile
April 20, 2023
7:31 am ET
Zacks
April 19, 2023
7:05 pm ET
Newsfile
April 14, 2023
8:15 pm ET
Newsfile
April 12, 2023
7:06 pm ET
Newsfile
April 10, 2023
7:33 pm ET
Newsfile
April 05, 2023
7:06 pm ET
Newsfile
April 01, 2023
7:00 am ET
PR Newswire
March 31, 2023
8:16 pm ET
Newsfile
March 30, 2023
6:53 pm ET
PR Newswire
March 29, 2023
7:06 pm ET
Newsfile
March 28, 2023
2:59 pm ET
PR Newswire
7:00 am ET
BusinessWire
March 24, 2023
8:15 pm ET
Newsfile
March 23, 2023
4:06 pm ET
BusinessWire
March 22, 2023
7:06 pm ET
Newsfile
March 20, 2023
7:33 pm ET
Newsfile
6:20 pm ET
Accesswire
March 19, 2023
4:10 pm ET
Globe Newswire
March 18, 2023
7:00 am ET
PR Newswire
March 17, 2023
8:15 pm ET
Newsfile
4:12 pm ET
PR Newswire
March 16, 2023
11:17 am ET
Accesswire
March 15, 2023
7:06 pm ET
Newsfile
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.